Cellectar Biosciences, Inc. - Common Stock — 재무제표 (NASDAQ:CLRB) | MetaTrader

전체 차트 열기 Full chart

뉴스

Cellectar Biosciences, Inc. (CLRB) Q1 2026 Earnings Call Transcript

Cellectar Biosciences (CLRB) Upgraded to Buy: Here's What You Should Know

Has Centene (CNC) Outpaced Other Medical Stocks This Year?

Why Bark Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket - Abivax (NASDAQ:ABVX), Rich Sparkle Holdings (NASDAQ:ANPA)

Cellectar secures multi-year supply of alpha-emitting radioisotopes

셀렉타 바이오사이언스, FDA 희귀 소아 질환 지정 후 급등

셀렉타, FDA 희귀 소아 의약품 지정 획득

Cellectar Biosciences stock soars after FDA grants rare pediatric designation

FDA grants rare pediatric drug designation to Cellectar’s cancer therapy

셀렉타, 실험용 암 치료제 췌장암 모델서 유망성 보여

Cellectar’s experimental cancer drug shows promise in pancreatic models

셀렉타 바이오사이언스, 워런트 행사로 580만 달러 조달